US 12,256,957

Application 18/405,315 · Granted Mar 25, 2025

Devices and methods for ablation of the skin

Estimated expiration

November 13, 2035

8y 358d remaining

Confidence: high
High: no high-severity warning was raised, and any terminal disclaimer was resolved to the patents it references.
Earliest effective filing
Nov 13, 2015
+ 20 years
Nov 13, 2035
PTA +0d
Nov 13, 2035
No TD
—
Final
Nov 13, 2035

This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.

Calculation details

Base term

Filing date
January 5, 2024
Earliest effective filing
November 13, 2015
Issue date
March 25, 2025
PTA
0 days
Base expiry (before PTA)
November 13, 2035

November 13, 2015 + 20 years = November 13, 2035

  • Continuation of application 17/709,542, filed Mar 31, 2022, issued as US 11,896,261
  • Continuation of application 15/526,299, filed May 11, 2017, issued as US 11,324,534
  • National stage entry of application PCTUS2015060685, filed Nov 13, 2015
  • National stage entry of application PCTUS2015060685, filed Nov 13, 2015
  • Continuation of application 15/526,299, filed May 11, 2017, issued as US 11,324,534
  • National stage entry of application PCTUS2015060685, filed Nov 13, 2015
  • PRO62/079,822 — Provisional — not used for base term
  • PRO62/079,822 — Provisional — not used for base term
  • PRO62/079,822 — Provisional — not used for base term
  • PRO62/079,822 — Provisional — not used for base term

Terminal disclaimers

No TD0 approved, 0 filed

Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated

You have the date. Your AI can have the file.

Application 18/405,315 · US 12,256,957

PatentReply compiles the prosecution history behind US 12,256,957: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.

One new published application a month is free. The first compile takes a few minutes.

Strategy and filing changes require your approval.

How PatentReply handles an Office Action response →

Permanent link

www.patentreply.ai/tools/patent-expiration/US12256957

Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.